The Burden of Chemotherapy-induced Myelosuppression

The Burden of Chemotherapy-induced Myelosuppression

0 0 about 1 month ago
In this episode of The Onco’Zine Brief Peter Hofland Ph.D., talks with Raj Malik M.D. and Robert Epstein M.D.

Malik is Chief Medical Officer and Senior Vice President, R&D, at G1 Therapeutics. He leads the company’s clinical development, medical affairs, regulatory affairs, biometrics, translational medicine and preclinical teams. Epstein is an epidemiologist with extensive expertise in pharmaco-economics and health outcomes research. He served in academia and public health prior to ... See More

Find us on Facebook